Mercer Global Advisors Inc Takeda Pharmaceutical CO LTD Transaction History

Mercer Global Advisors Inc

$45.6 Billion
Q3 2024

A detailed history of Mercer Global Advisors Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Mercer Global Advisors Inc holds 179,270 shares of TAK stock, worth $2.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

179,270

Previous 170,056 5.42%

Holding current value

$2.41 Million

Previous $2.2 Million 15.77%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$13.0 - $15.08 $119,782 - $138,947	9,214 Added 5.42%	179,270 $2.55 Million
Q2 2024 Aug 12, 2024	SELL	$12.6 - $13.67 $501,253 - $543,819	-39,782 Reduced 18.96%	170,056 $2.2 Million
Q1 2024 May 15, 2024	SELL	$13.89 - $15.04 $40,739 - $44,112	-2,933 Reduced 1.38%	209,838 $2.92 Million
Q4 2023 Feb 14, 2024	SELL	$13.36 - $15.43 $620,425 - $716,553	-46,439 Reduced 17.92%	212,771 $3.04 Million
Q3 2023 Nov 13, 2023	BUY	$15.03 - $16.32 $1.36 Million - $1.48 Million	90,669 Added 53.8%	259,210 $4.01 Million
Q2 2023 Aug 14, 2023	BUY	$15.57 - $17.11 $358,514 - $393,974	23,026 Added 15.82%	168,541 $2.65 Million
Q1 2023 May 15, 2023	BUY	$15.28 - $16.48 $210,084 - $226,583	13,749 Added 10.43%	145,515 $2.4 Million
Q4 2022 Feb 08, 2023	BUY	$12.42 - $15.62 $153,461 - $193,000	12,356 Added 10.35%	131,766 $2.06 Million
Q3 2022 Nov 15, 2022	BUY	$12.8 - $28.65 $26,995 - $60,422	2,109 Added 1.8%	119,410 $1.55 Million
Q2 2022 Aug 10, 2022	BUY	$13.12 - $15.03 $76,765 - $87,940	5,851 Added 5.25%	117,301 $1.65 Million
Q1 2022 May 10, 2022	BUY	$13.54 - $15.35 $400,377 - $453,899	29,570 Added 36.11%	111,450 $1.6 Million
Q4 2021 Feb 04, 2022	SELL	$13.17 - $16.4 $98,156 - $122,229	-7,453 Reduced 8.34%	81,880 $1.12 Million
Q3 2021 Nov 10, 2021	BUY	$16.3 - $17.26 $158,158 - $167,473	9,703 Added 12.19%	89,333 $1.46 Million
Q2 2021 Aug 10, 2021	SELL	$16.55 - $18.64 $107,210 - $120,749	-6,478 Reduced 7.52%	79,630 $1.34 Million
Q1 2021 May 11, 2021	SELL	$16.71 - $19.9 $22,825 - $27,183	-1,366 Reduced 1.56%	86,108 $1.57 Million
Q4 2020 Feb 12, 2021	SELL	$15.39 - $18.97 $43,692 - $53,855	-2,839 Reduced 3.14%	87,474 $1.59 Million
Q3 2020 Dec 10, 2020	BUY	$17.1 - $19.19 $57,712 - $64,766	3,375 Added 3.88%	90,313 $1.61 Million
Q2 2020 Aug 10, 2020	BUY	$14.59 - $19.5 $452,713 - $605,065	31,029 Added 55.5%	86,938 $1.56 Million
Q1 2020 May 18, 2020	BUY	$13.02 - $20.31 $260,452 - $406,281	20,004 Added 55.71%	55,909 $849,000
Q4 2019 Feb 13, 2020	SELL	$16.88 - $20.83 $86,915 - $107,253	-5,149 Reduced 12.54%	35,905 $708,000
Q3 2019 Nov 12, 2019	BUY	$16.15 - $17.99 $94,994 - $105,817	5,882 Added 16.72%	41,054 $706,000
Q2 2019 Aug 14, 2019	SELL	$16.58 - $20.49 $15,237 - $18,830	-919 Reduced 2.55%	35,172 $623,000
Q1 2019 Apr 23, 2019	BUY	$16.7 - $21.52 $201,819 - $260,069	12,085 Added 50.34%	36,091 $735,000
Q1 2019 Apr 12, 2019	BUY	$16.7 - $21.52 $400,900 - $516,609	24,006 New	24,006 $404,000

Others Institutions Holding TAK

# of Institutions

334

Shares Held

68.5M

Call Options Held

1.96M

Put Options Held

165K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.8B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Takeda Pharmaceutical CO LTD Transaction History